CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 407 enrolled
Drug / intervention
Amoxicillin, Clarythromycin, Omeprazole for ten daysdrug
Likely dose
Amoxicillin, Clarythromycin, Omeprazole for ten days 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00404534
NCT00404534Phase 3Completed
CompareCT.gov

Dyspeptic Symptoms Evolution After Eradication of Helicobacter Pylori in Patients With Different Endoscopic Findings: a Randomized Double-blind Placebo-controlled Clinical Trial With 12 Months of Follow-up

Hospital de Clinicas de Porto Alegre·interventional·Posted Nov 28, 2006·Updated Mar 1, 2018

In Brief

A Phase 3 clinical trial evaluating Amoxicillin, Clarythromycin, Omeprazole for ten days for Functional Dyspepsia. Completed, enrolled 407 participants across 1 site.

Detailed Summary

A double-blind clinical trial investigating if a sub-group of functional dyspeptic patients without any use of NSAID or gastric erosions could have a better evolution of their dyspeptic symptoms after Helicobacter eradication than the placebo control group

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFunctional Dyspepsia
CountriesBrazil
CollaboratorsAché Laboratórios Farmacêuticos Ltda

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 28, 2006
Enrollment StartOct 1, 2006
Primary CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 19.6 years ago

Interventions

Amoxicillin, Clarythromycin, Omeprazole for ten daysdrug

Amoxicillin 1000 mg BID, clarythromycin 500 mg BID for ten days in the experimental group and placebo of Amoxicillin 1000 mg BID and placebo of clarythromycin 500 mg BID in the placebo comparator. Both groups receive omeprazole 20 mg bid for 10 days.